Users Stopping Anti-Obesity Medications Regain Pounds Far More Rapidly Compared to Dieters
New research suggests that individuals who come off new slimming jabs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise plans.
Findings released in a prominent health publication demonstrates that while obese individuals often shed a large proportion of their total mass while on the medication, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Users buying such medications must be aware of the danger of quick weight regain when the medication ends," warns lead investigator Dr. Susan Jebb.
This pace of recovery suggests a return to starting mass in about 18 months.
Comparing Treatments
The analysis, which examined 37 of studies involving over 9,000 of patients, contrasted the effects of these new drugs with older methods.
Scientists emphasize that individuals who lose weight through lifestyle changes alone usually have a more gradual weight regain—around 0.1 kg a month—after stopping.
The Reason for the Fast Regain
Experts propose the way of the jabs accounts for the heightened regain.
These medications imitate a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing the hormone levels far above than the body's typical production may cause the system to produce less of its own natural GLP-1, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement leads to hunger is unsuppressed, making overeating a significant risk."
An Ongoing Condition?
Medical guidelines advise the injections for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
Professionals argue that, given the significant potential of weight regain, the therapy is often life-long.
This perspective is reinforced by drug manufacturers, who state that the results "emphasize the chronic nature of excess weight," akin to managing conditions like high blood pressure.
Patient Experiences
People who have stopped the medication describe a intense resurgence of cravings.
"It was like something activating and you become starving," said one woman.
This challenge is compounded if users have not adopted sustainable lifestyle or habit modifications during therapy.
Growing Interest
Survey data suggest that millions of people in the UK have tried weight-loss jabs in the past year, with interest being substantial.
- Use is higher among women than males.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
Finally, clinicians stress that while these medications are powerful agents for shedding pounds, they are not a standalone fix and long-term success hinges on ongoing lifestyle changes.
